260 related articles for article (PubMed ID: 19563505)
1. Angiogenic and lymphangiogenic microvessel density in recurrent pleomorphic adenoma.
Soares AB; de Araújo VC; Juliano PB; Altemani A
J Oral Pathol Med; 2009 Sep; 38(8):623-9. PubMed ID: 19563505
[TBL] [Abstract][Full Text] [Related]
2. Study of histopathological, morphological and immunohistochemical features of recurrent pleomorphic adenoma: an attempt to predict recurrence of pleomorphic adenoma.
Soares AB; Altemani A; de Araújo VC
J Oral Pathol Med; 2011 Apr; 40(4):352-8. PubMed ID: 20969626
[TBL] [Abstract][Full Text] [Related]
3. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland.
Glas AS; Hollema H; Nap RE; Plukker JT
Cancer; 2002 Apr; 94(8):2211-6. PubMed ID: 12001119
[TBL] [Abstract][Full Text] [Related]
4. Evidence of lymphangiogenesis in Warthin's tumor of the parotid gland.
Teymoortash A; Schrader C; Shimoda H; Kato S; Werner JA
Oral Oncol; 2007 Jul; 43(6):614-8. PubMed ID: 16996778
[TBL] [Abstract][Full Text] [Related]
5. Recurrent pleomorphic adenoma of the parotid gland: a prospective histopathological and immunohistochemical study.
Stennert E; Wittekindt C; Klussmann JP; Arnold G; Guntinas-Lichius O
Laryngoscope; 2004 Jan; 114(1):158-63. PubMed ID: 14710014
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic vascular density and lymphangiogenesis during tumour progression of carcinoma ex pleomorphic adenoma.
Soares AB; Ponchio L; Juliano PB; de Araújo VC; Altemani A
J Clin Pathol; 2007 Sep; 60(9):995-1000. PubMed ID: 17079351
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of cyclooxygenase-2 and Ki-67 are associated with malignant transformation of pleomorphic adenoma.
Katori H; Nozawa A; Tsukuda M
Auris Nasus Larynx; 2007 Mar; 34(1):79-84. PubMed ID: 17049779
[TBL] [Abstract][Full Text] [Related]
8. Pleomorphic adenoma with mucinous and squamous differentiation: a mimicker of mucoepidermoid carcinoma.
Guo SP; Cheuk W; Chan JK
Int J Surg Pathol; 2009 Aug; 17(4):335-7. PubMed ID: 19443870
[TBL] [Abstract][Full Text] [Related]
9. [Proliferative activity in recurrent and nonrecurrent pleomorphic adenoma of the salivary glands].
Bankamp DG; Bierhoff E
Laryngorhinootologie; 1999 Feb; 78(2):77-80. PubMed ID: 10226990
[TBL] [Abstract][Full Text] [Related]
10. Pleomorphic adenoma of the salivary glands with intravascular tumor deposits: a diagnostic pitfall.
Skalova A; Altemani A; Di Palma S; Simpson RH; Hosticka L; Andrle P; Laco J; Toner M; Vozmitsel MA; Szakacs S; Kazakov DV; Kinkor Z; Michal M
Am J Surg Pathol; 2012 Nov; 36(11):1674-82. PubMed ID: 23073326
[TBL] [Abstract][Full Text] [Related]
11. An immunohistochemical study of XIAP expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Hoch BL; Wu M; Lewis M; Gan L; Burstein DE
J Oral Pathol Med; 2008 Nov; 37(10):634-8. PubMed ID: 18673415
[TBL] [Abstract][Full Text] [Related]
12. Expression of epidermal growth factor receptor, transforming growth factor-alpha and Ki-67 in relationship to malignant transformation of pleomorphic adenoma.
Katori H; Nozawa A; Tsukuda M
Acta Otolaryngol; 2007 Nov; 127(11):1207-13. PubMed ID: 17851915
[TBL] [Abstract][Full Text] [Related]
13. The increased PDGF-A, PDGF-B and FGF-2 expression in recurrence of salivary gland pleomorphic adenoma.
Soares AB; Demasi AP; Tincani AJ; Martins AS; Altemani A; de Araújo VC
J Clin Pathol; 2012 Mar; 65(3):272-7. PubMed ID: 22174424
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclooxygenase-2, Bcl-2 and Ki-67 in pleomorphic adenoma with special reference to tumor proliferation and apoptosis.
Aoki T; Tsukinoki K; Karakida K; Ota Y; Otsuru M; Kaneko A
Oral Oncol; 2004 Oct; 40(9):954-9. PubMed ID: 15380175
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and fibroblast proliferation precede formation of recurrent tumors after radiation therapy in nude mice.
Hast J; Schiffer IB; Neugebauer B; Teichman E; Schreiber W; Brieger J; Kim DW; Gebhard S; Born CJ; Strugala M; Sagemüller J; Brenner W; Mann WJ; Oesch F; Thelen M; Hengstler JG
Anticancer Res; 2002; 22(2A):677-88. PubMed ID: 12014637
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and lymphangiogenesis in sporadic hepatic angiomyolipoma.
Xian ZH; Cong WM; Lu XY; Yu H; Wu MC
Pathol Res Pract; 2011 Jul; 207(7):403-9. PubMed ID: 21665376
[TBL] [Abstract][Full Text] [Related]
17. Increase in Chymase-Positive Mast Cells in Recurrent Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland.
Kinoshita I; Jin D; Higashino M; Terada T; Kurisu Y; Takai S; Kawata R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884420
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications.
Mohammed RA; Ellis IO; Elsheikh S; Paish EC; Martin SG
Breast Cancer Res Treat; 2009 Jan; 113(2):261-73. PubMed ID: 18293084
[TBL] [Abstract][Full Text] [Related]
19. Pleomorphic adenoma of salivary gland: to what extent does fine needle aspiration cytology reflect histopathological features?
Das DK; Anim JT
Cytopathology; 2005 Apr; 16(2):65-70. PubMed ID: 15787647
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 and p16 expression in pleomorphic adenoma and carcinoma ex pleomorphic adenoma of the parotid gland.
Patel RS; Rose B; Bawdon H; Hong A; Lee CS; Fredericks S; Gao K; O'Brien CJ
Histopathology; 2007 Nov; 51(5):691-6. PubMed ID: 17927591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
